BioStacks
About BioStacks
BioStacks is a health and fitness application that allows users to scan any supplement and verify whether the doses match those found in clinical trials. The platform features 299 clinical actives and provides insights based on 20 health goals, utilizing algorithms that cater to different health needs rather than a one-size-fits-all approach. Each ingredient is linked to reputable sources such as the NIH Office of Dietary Supplements and Examine.com, ensuring transparency and reliability in the information provided.
The app aims to help users avoid paying for sub-therapeutic doses by allowing…
The headline here is rapid percentage growth from a very small base: +177% growth with $1,014 in the last 30 days shows commercial traction and demand for the core feature. MRR of $210 versus the higher recent 30-day revenue suggests a meaningful portion of this month's intake may be one-time purchases or newly closed sales rather than stable subscription income.
Product-market fit looks narrowly focused — a tool that scores supplement labels and barcodes can attract a specific set of consumers who care about supplement efficacy. With founding in 2026 and revenue-stage status, the startup is at an early commercial validation phase; scaling will hinge on increasing acquisition beyond the current very low traffic and on establishing credibility (accuracy, sources of analysis, and any regulatory positioning).
— Strengths
— What to watch
◆ Best suited for
A judgment from project data — not a user review.
